Where does AR & NS Investment, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), AR & NS Investment, LLC ranks #7,976 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does AR & NS Investment, LLC hold?

AR & NS Investment, LLC holds 40 US utility patents granted between 2020 and 2025, spanning 14 technology areas.

What is AR & NS Investment, LLC's Innovation Score?

AR & NS Investment, LLC has an Innovation Score of 57.7 out of 100 (top 5% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does AR & NS Investment, LLC focus on?

AR & NS Investment, LLC's top technology area is H04B (Transmission) with 21 patents, ranking #429 of 3,909 assignees active in that subclass. Grants appear in 14 CPC subclasses total.

Is AR & NS Investment, LLC's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for AR & NS Investment, LLC.

What does claim depth mean for AR & NS Investment, LLC's patents?

AR & NS Investment, LLC's patents average 19.5 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the AR & NS Investment, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

AR & NS Investment, LLC

USPTO PatentsView assignee record - 40 granted patents across 14 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H04B (Transmission).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, AR ranks #7,976 of 49,997 tracked US assignees by granted-patent volume, with 40 patents across 14 technology areas.

#7,976
of 49,997 US assignees by volume: Top 5%
by Innovation Score (57.7/100): 19.5
avg claims per patent

USPTO PatentsView assignee plate

Corpus R7976 · US Corporation #7,976 · 40 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-SMALL 40 grants
UPPER-Q #7,976/49,997
PHOTO-FINISH Abbvie Stemcentrx
CPC-FOCUS H04B · 14 areas
INNOV-PAR 57.7/100
CLAIMS-RICH 19.5 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Abbvie Stemcentrx LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How AR’s 57.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.8 pts (22%) Velocity 20.0 pts (35%) Breadth 13.2 pts (23%) Claim depth 11.7 pts (20%)

Qualcomm Incorporated · highest

85
Clarios Germany & KG · near

58
Koninklijke Douwe… · near

58
Zoetis Services · near

58
AR & NS Investment · this assignee

58
International Paper · near

58
3D Lighting… · lowest

7

What this shows AR's Innovation Score is 57.7/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for AR?

Each dot is one of AR’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). AR’s own 19.5 claims/patent is ABOVE the 17.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

AR vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where AR's grants concentrate

AR & NS Investment, LLC is a focused PatentsView assignee: 14 CPC subclasses with 52.5% of grants classified under H04B (Transmission). Peak complete grant year is 2023 (14 grants) versus a trough of 1 in 2020. By volume, AR sits between Abbvie Stemcentrx LLC and ActiveVideo Networks, LLC.

AR's three-year grant acceleration

AR & NS Investment, LLC shows 33 grants in 2022–2024 against only 4 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Abbvie Stemcentrx

40
Alios Biopharma

40
Amcor Rigid Packa…

40
Anchor Hocking

40
ARK Therapeutic S…

40
Automated Assembly

40
Azurity Pharmaceu…

40
Activevideo Netwo…

40
AR & NS Investment ◀

40

What this shows AR holds 40 patents at rank #7,973, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near AR

By rank, the assignees closest to #7,973 in granted patent volume.

Leaders in H04B (Transmission)

Other assignees with the most granted patents in AR's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for AR, neither rank-band nor same-CPC leaders (those blocks stay above). In H04B (Transmission), AR ranks #429 of 3,909 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (58 here).

International Paper Company 58 Clarios Germany GmbH & Co. KG 58 Koninklijke Douwe Egberts B.V. 58 Zoetis Services LLC 58

AR's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

58 Top 5% higher than 95% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

AR & NS Investment, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	2.5%
2021	3	7.5%
2022	7	17.5%
2023	14	35.0%
2024	12	30.0%
2025partial year	3	7.5%

Which technologies does AR & NS Investment, LLC patent most?

H04B - Transmission 21

H04W - Wireless Communication Networks 15

G06F - Electric Digital Data Processing 7

A61B - DIAGNOSIS; SURGERY; Identification 7

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 7

G06N - Computing Arrangements Based ON Specific Computational Models 6

G06V - Image OR Video Recognition OR Understanding 4

A63B - Apparatus FOR Physical Training, Gymnastics, Swimming, Climbing, OR FENCING; Ball GAMES; Training Equipment 3

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 3

G06T - Image Data Processing OR Generation, IN General 3

B25J - MANIPULATORS; Chambers Provided With Manipulation Devices 3

G01S - Radio DIRECTION-FINDING; Radio NAVIGATION; Determining Distance OR Velocity BY USE OF Radio WAVES; Locating OR Presence-detecting BY USE OF THE Reflection OR Reradiation OF Radio WAVES; Analogous Arrangements Using Other Waves 1

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 14 of 14 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

AR & NS Investment, LLC's patent record in context - here's where to go next.

AR & NS Investment, LLC's lead technology class is H04B (Transmission), 52.5% of its portfolio - see every assignee active in that class. Explore H04B
Ranked #7,976 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare AR & NS Investment, LLC against Abbvie Stemcentrx LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 57.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.